Based on previous results from different laboratories, including our own, we postulate that inactivation of suppressor genes may complement the activation of the Ha-ras gene for the acquisition of a fully malignant phenotype (squamous cell carcinoma) in chemically induced skin carcinogenesis. The long term goals of this project are to show the role of tumor suppression function in this system, to identify the putative suppressor genes, and to investigate tumor suppressor mechanisms. The induction of squamous cell carcinomas (SCC) in the mouse skin by 2-stage protocols is a reliable, reproducible model in which many molecular and cellular aspects of carcinogenesis have been described and intermediate premalignant stages have been characterized, histologically, cytogenetically and biochemically. Therefore, this model appears to be ideal to investigate the tumor suppression phenomenon, not only to gain understanding of the pathobiology of human SCC, but also to elucidate general mechanisms of chemical carcinogenesis. We propose, in this project, to study the suppression phenomenon in the mouse skin system following the same approach that has been successfully used to show tumor suppression in other systems: cell fusion techniques and detection of allelic losses. Cell fusion experiments between normal and tumoral cells will show the existence of tumor suppression in this model and will also signal the chromosomal location of putative suppressor genes. The loss of heterozygosity (LOH) of polymorphic genes, a sensitive indicator of chromosomal deletion and/or allelic loss, will be used to detect putative areas of the genome with suppressor function.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA053123-05
Application #
2095200
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1991-01-01
Project End
1995-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Organized Research Units
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Xu, J; Gimenez-Conti, I B; Cunningham, J E et al. (1998) Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 83:204-12
Zenklusen, J C; Hodges, L C; Conti, C J (1997) Loss of heterozygosity on murine chromosome 6 in two-stage carcinogenesis: evidence for a conserved tumor suppressor gene. Oncogene 14:109-14
Conti, C J; Gimenez-Conti, I B (1996) Molecular genetic alterations as intermediate end points in chemoprevention studies. IARC Sci Publ :249-60
Zenklusen, J C; Rodriguez, L V; LaCava, M et al. (1996) Novel susceptibility locus for mouse hepatomas: evidence for a conserved tumor suppressor gene. Genome Res 6:1070-6
Stern, M C; Gimenez-Conti, I B; Conti, C J (1995) Genetic susceptibility to papilloma progression in SENCAR mice. Carcinogenesis 16:1947-53
Zenklusen, J C; Thompson, J C; Klein-Szanto, A J et al. (1995) Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res 55:1347-50
Zenklusen, J C; Oshimura, M; Barrett, J C et al. (1995) Human chromosome 11 inhibits tumorigenicity of a murine squamous cell carcinoma cell line. Genes Chromosomes Cancer 13:47-53
Zenklusen, J C; Weitzel, J N; Ball, H G et al. (1995) Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene 11:359-63
Zenklusen, J C; Thompson, J C; Troncoso, P et al. (1994) Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Res 54:6370-3
Zenklusen, J C; Bieche, I; Lidereau, R et al. (1994) (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci U S A 91:12155-8

Showing the most recent 10 out of 16 publications